Cargando…

The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure

The liver has been thought to protect against oxidative stress through mechanisms involving reduced glutathione (GSH) that consumes high-energy phosphor-nucleotides on its synthesis. However, hepatoprotective mechanisms in acute liver failure (ALF) where the phosphor-nucleotides are decreased in rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizota, Takamasa, Hishiki, Takako, Shinoda, Masahiro, Naito, Yoshiko, Hirukawa, Kazuya, Masugi, Yohei, Itano, Osamu, Obara, Hideaki, Kitago, Minoru, Yagi, Hiroshi, Abe, Yuta, Matsubara, Kentaro, Suematsu, Makoto, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: the Society for Free Radical Research Japan 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764102/
https://www.ncbi.nlm.nih.gov/pubmed/35068682
http://dx.doi.org/10.3164/jcbn.21-50
_version_ 1784634090423582720
author Mizota, Takamasa
Hishiki, Takako
Shinoda, Masahiro
Naito, Yoshiko
Hirukawa, Kazuya
Masugi, Yohei
Itano, Osamu
Obara, Hideaki
Kitago, Minoru
Yagi, Hiroshi
Abe, Yuta
Matsubara, Kentaro
Suematsu, Makoto
Kitagawa, Yuko
author_facet Mizota, Takamasa
Hishiki, Takako
Shinoda, Masahiro
Naito, Yoshiko
Hirukawa, Kazuya
Masugi, Yohei
Itano, Osamu
Obara, Hideaki
Kitago, Minoru
Yagi, Hiroshi
Abe, Yuta
Matsubara, Kentaro
Suematsu, Makoto
Kitagawa, Yuko
author_sort Mizota, Takamasa
collection PubMed
description The liver has been thought to protect against oxidative stress through mechanisms involving reduced glutathione (GSH) that consumes high-energy phosphor-nucleotides on its synthesis. However, hepatoprotective mechanisms in acute liver failure (ALF) where the phosphor-nucleotides are decreased in remain to be solved. Liver tissues were collected from patients with ALF and liver cirrhosis (LC) and living donors (HD) who had undergone liver transplantation. Tissues were used for metabolomic analyses to determine metabolites belonging to the central carbon metabolism, and to determine sulfur-containing metabolites. ALF and LC exhibited a significant decline in metabolites of glycolysis and pentose phosphate pathways and high-energy phosphor-nucleotides such as adenosine triphosphate as compared with HD. Conversely, methionine, S-adenosyl-l-methionine, and the ratio of serine to 3-phosphoglycerate were elevated significantly in ALF as compared with LC and HD, suggesting a metabolic boost from glycolysis towards trans-sulfuration. Notably in ALF, the increases in hypotaurine (HTU) + taurine (TU) coincided with decreases in the total amounts of reduced and oxidized glutathione (GSH + 2GSSG). Plasma NH(3) levels correlated with the ratio of HTU + TU to GSH + 2GSSG. Increased tissue levels of HTU + TU vs total glutathione appear to serve as a biomarker correlating with hyperammonemia, suggesting putative roles of the HTU-TU pathway in anti-oxidative protective mechanisms.
format Online
Article
Text
id pubmed-8764102
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher the Society for Free Radical Research Japan
record_format MEDLINE/PubMed
spelling pubmed-87641022022-01-21 The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure Mizota, Takamasa Hishiki, Takako Shinoda, Masahiro Naito, Yoshiko Hirukawa, Kazuya Masugi, Yohei Itano, Osamu Obara, Hideaki Kitago, Minoru Yagi, Hiroshi Abe, Yuta Matsubara, Kentaro Suematsu, Makoto Kitagawa, Yuko J Clin Biochem Nutr Original Article The liver has been thought to protect against oxidative stress through mechanisms involving reduced glutathione (GSH) that consumes high-energy phosphor-nucleotides on its synthesis. However, hepatoprotective mechanisms in acute liver failure (ALF) where the phosphor-nucleotides are decreased in remain to be solved. Liver tissues were collected from patients with ALF and liver cirrhosis (LC) and living donors (HD) who had undergone liver transplantation. Tissues were used for metabolomic analyses to determine metabolites belonging to the central carbon metabolism, and to determine sulfur-containing metabolites. ALF and LC exhibited a significant decline in metabolites of glycolysis and pentose phosphate pathways and high-energy phosphor-nucleotides such as adenosine triphosphate as compared with HD. Conversely, methionine, S-adenosyl-l-methionine, and the ratio of serine to 3-phosphoglycerate were elevated significantly in ALF as compared with LC and HD, suggesting a metabolic boost from glycolysis towards trans-sulfuration. Notably in ALF, the increases in hypotaurine (HTU) + taurine (TU) coincided with decreases in the total amounts of reduced and oxidized glutathione (GSH + 2GSSG). Plasma NH(3) levels correlated with the ratio of HTU + TU to GSH + 2GSSG. Increased tissue levels of HTU + TU vs total glutathione appear to serve as a biomarker correlating with hyperammonemia, suggesting putative roles of the HTU-TU pathway in anti-oxidative protective mechanisms. the Society for Free Radical Research Japan 2022-01 2021-06-26 /pmc/articles/PMC8764102/ /pubmed/35068682 http://dx.doi.org/10.3164/jcbn.21-50 Text en Copyright © 2022 JCBN https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Original Article
Mizota, Takamasa
Hishiki, Takako
Shinoda, Masahiro
Naito, Yoshiko
Hirukawa, Kazuya
Masugi, Yohei
Itano, Osamu
Obara, Hideaki
Kitago, Minoru
Yagi, Hiroshi
Abe, Yuta
Matsubara, Kentaro
Suematsu, Makoto
Kitagawa, Yuko
The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure
title The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure
title_full The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure
title_fullStr The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure
title_full_unstemmed The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure
title_short The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure
title_sort hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764102/
https://www.ncbi.nlm.nih.gov/pubmed/35068682
http://dx.doi.org/10.3164/jcbn.21-50
work_keys_str_mv AT mizotatakamasa thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT hishikitakako thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT shinodamasahiro thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT naitoyoshiko thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT hirukawakazuya thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT masugiyohei thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT itanoosamu thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT obarahideaki thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT kitagominoru thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT yagihiroshi thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT abeyuta thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT matsubarakentaro thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT suematsumakoto thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT kitagawayuko thehypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT mizotatakamasa hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT hishikitakako hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT shinodamasahiro hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT naitoyoshiko hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT hirukawakazuya hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT masugiyohei hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT itanoosamu hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT obarahideaki hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT kitagominoru hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT yagihiroshi hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT abeyuta hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT matsubarakentaro hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT suematsumakoto hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure
AT kitagawayuko hypotaurinetaurinepathwayasanantioxidativemechanisminpatientswithacuteliverfailure